Nivolumab

Immunoglobulin G4-kappa, anti-[Homo sapiens PDCD1 (programmed cell death 1, PD-1, PD1, CD279)], Homo sapiens monoclonal antibody

Stoffgruppe

Antineoplastisches Mittel (Checkpoint-Inhibitor)